Genocea Biosciences (GNCA) Short Interest Ratio & Short Volume → The ONE AI sSock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free GNCA Stock Alerts Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsSocial Media Genocea Biosciences Short Interest DataCurrent Short Volume3,590,000 sharesPrevious Short Volume1,640,000 sharesChange Vs. Previous Month+118.90%Dollar Volume Sold Short$218,990.00Short Interest Ratio / Days to Cover0.4Last Record DateMay 31, 2022Outstanding Shares58,730,000 sharesFloat Size26,440,000 sharesShort Percent of Float13.58%Today's Trading Volume0 sharesAverage Trading Volume83,499 sharesToday's Volume Vs. Average0% Short Selling Genocea Biosciences ? Sign up to receive the latest short interest report for Genocea Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGNCA Short Interest Over TimeGNCA Days to Cover Over TimeGNCA Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Genocea Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20223,590,000 shares $218,990.00 +118.9%13.6%0.4 $0.06 5/15/20221,640,000 shares $369,000.00 -12.3%4.0%0.7 $0.23 4/30/20221,870,000 shares $529,771.00 -37.0%4.5%1.1 $0.28 4/15/20222,970,000 shares $1.37 million +106.3%7.2%1.9 $0.46 3/31/20221,440,000 shares $1.80 million +5.1%3.5%4.3 $1.25 3/15/20221,370,000 shares $1.52 million +3.0%3.4%2.6 $1.11 Get the Latest News and Ratings for GNCA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genocea Biosciences and its competitors with MarketBeat's FREE daily newsletter. 2/28/20221,330,000 shares $1.30 million -1.5%3.3%2.5 $0.98 2/15/20221,350,000 shares $1.51 million -2.9%3.3%2.6 $1.12 1/31/20221,390,000 shares $1.47 million -5.4%3.4%2.6 $1.06 1/15/20221,470,000 shares $1.51 million -8.1%3.5%2.7 $1.03 12/31/20211,600,000 shares $1.86 million +8.8%3.8%3 $1.16 12/15/20211,470,000 shares $1.43 million -2.0%3.6%3.1 $0.97 11/30/20211,500,000 shares $2.03 million -4.5%3.6%8.2 $1.35 11/15/20211,570,000 shares $2.56 million -0.6%3.8%8.1 $1.63 10/29/20211,580,000 shares $3.02 million +6.8%3.8%8.4 $1.91 10/15/20211,480,000 shares $2.60 million No Change3.6%8.5 $1.76 9/30/20211,480,000 shares $2.84 million +0.7%3.6%8.4 $1.92 9/15/20211,470,000 shares $2.62 million +1.4%3.6%9.3 $1.78 8/31/20211,450,000 shares $2.55 million No Change3.5%9.4 $1.76 8/13/20211,450,000 shares $2.62 million -1.4%3.5%8 $1.81 7/30/20211,470,000 shares $2.97 million -3.3%3.6%7.3 $2.02 7/15/20211,520,000 shares $3.22 million -0.7%3.9%6.5 $2.12 6/30/20211,530,000 shares $3.58 million -1.9%4.0%5.8 $2.34 6/15/20211,560,000 shares $3.88 million -4.3%4.0%5.4 $2.49 5/28/20211,630,000 shares $3.85 million -5.2%4.2%5.1 $2.36 5/14/20211,720,000 shares $3.54 million -2.8%N/A5.5 $2.06 4/30/20211,770,000 shares $4.71 million +9.9%N/A4.2 $2.66 4/15/20211,610,000 shares $4.03 million No ChangeN/A3.2 $2.50 3/31/20211,610,000 shares $4.19 million -3.6%N/A2.8 $2.60 3/15/20211,670,000 shares $4.94 million +10.6%N/A2.8 $2.96 2/26/20211,510,000 shares $4.50 million -10.7%N/A2.5 $2.98 2/12/20211,690,000 shares $5.54 million -5.6%N/A2.9 $3.28 1/29/20211,790,000 shares $5.23 million +6.6%N/A3.3 $2.92 1/15/20211,680,000 shares $4.96 million +3.1%N/A3.6 $2.95 12/31/20201,630,000 shares $4.29 million No ChangeN/A4.7 $2.63 12/15/20201,630,000 shares $3.44 million -4.7%N/A4.8 $2.11 11/30/20201,710,000 shares $3.56 million +5.6%N/A4.4 $2.08 11/15/20201,620,000 shares $3.35 million -14.3%N/A4.1 $2.07 10/30/20201,890,000 shares $4.01 million +12.5%N/A4.4 $2.12 10/15/20201,680,000 shares $4.27 million -4.0%N/A1.9 $2.54AI Cracks Open Largest Untapped Energy Reserve on Earth (Ad)This orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… ]click here to watch a free presentation where I reveal all the details of this lucrative opportunit GNCA Short Interest - Frequently Asked Questions What is Genocea Biosciences' current short interest? Short interest is the volume of Genocea Biosciences shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 3,590,000 shares of GNCA short. 13.58% of Genocea Biosciences' shares are currently sold short. Learn More on Genocea Biosciences' current short interest. What is a good short interest percentage for Genocea Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.58% of Genocea Biosciences' floating shares are currently sold short. Is Genocea Biosciences' short interest increasing or decreasing? Genocea Biosciences saw a increase in short interest in the month of May. As of May 31st, there was short interest totaling 3,590,000 shares, an increase of 118.9% from the previous total of 1,640,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Genocea Biosciences' float size? Genocea Biosciences currently has issued a total of 58,730,000 shares. Some of Genocea Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Genocea Biosciences currently has a public float of 26,440,000 shares. How does Genocea Biosciences' short interest compare to its competitors? 13.58% of Genocea Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Genocea Biosciences: Scinai Immunotherapeutics Ltd. (0.45%), TC Biopharm (Holdings) Plc (28.97%), Eloxx Pharmaceuticals, Inc. (1.49%), Palisade Bio, Inc. (0.85%), Avalon GloboCare Corp. (6.88%), Finch Therapeutics Group, Inc. (0.45%), NanoString Technologies, Inc. (12.55%), Fresh Tracks Therapeutics, Inc. (0.17%), Titan Pharmaceuticals, Inc. (2.23%), Creative Medical Technology Holdings, Inc. (0.93%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.12 billion), Palo Alto Networks, Inc. ($3.85 billion), Lucid Group, Inc. ($2.66 billion), HP Inc. ($2.31 billion), Coinbase Global, Inc. ($2.14 billion), GameStop Corp. ($1.94 billion), T. Rowe Price Group, Inc. ($1.91 billion), Chesapeake Energy Co. ($1.79 billion), Rivian Automotive, Inc. ($1.62 billion), and Carnival Co. & plc ($1.59 billion). View all of the most shorted stocks. What does it mean to sell short Genocea Biosciences stock? Short selling GNCA is an investing strategy that aims to generate trading profit from Genocea Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Genocea Biosciences? A short squeeze for Genocea Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GNCA, which in turn drives the price of the stock up even further. How often is Genocea Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNCA, twice per month. The most recent reporting period available is May, 31 2022. More Short Interest Resources from MarketBeat Related Companies: Scinai Immunotherapeutics Short Interest Data TC Biopharm Short Interest Data Eloxx Pharmaceuticals Short Interest Data Palisade Bio Short Interest Data Avalon GloboCare Short Interest Data Finch Therapeutics Group Short Interest Data NanoString Technologies Short Interest Data Fresh Tracks Therapeutics Short Interest Data Titan Pharmaceuticals Short Interest Data Creative Medical Technology Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GNCA) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaBiden out June 13?Paradigm PressMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThe world’s greatest investmentPorter & CompanyBuy this small stock before coming AI Tidal WaveChaikin AnalyticsStock-Picking AI Predicts #1 Stock of 2024Altimetry